IL1B and heart failure: IL-1 blockers are being studied for the prevention and treatment of heart failure, showing a promising safety and efficacy profile [30–35] thus introducing the possibility of future clinical trials investigating IL-1 blockade to treat patients at risk for radiation-induced heart failure.